Self Testing Market Size, Share, Application Analysis and Growth by Forecast to 2022-2030

 Self-testing kit sales are estimated to be worth US$ 7.49 billion globally. The market is anticipated to rise at a strong CAGR of 5.6% to reach US$ 11.55 Billion by 2030.


Self-Testing is opening new ways to monitor, diagnose, and address patients and their treatment. Manufacturers are developing testing kits for wellness and prevention strategies, ranging from chronic disorder management and acute infection diagnoses to detect the potential risks of ailments. Testing for drugs of abuse in the medical field is constructing new inroads into the domain of pain management, primarily owing to the increased usage of opioids for the treatment of chronic diseases as well as mortality and morbidity related to misuse of these drugs.

Get Full Access@ https://www.futuremarketinsights.com/reports/self-testing-market

Key Findings of the Study

  • Global revenues will grow at 5.5% CAGR over forecast period, 2020-2030
  • Blood glucose testing to hold prominent share in self-testing market, owing to high prevalence rate of diabetes
  • Self-testing kits for testing urine and blood samples to account for greater demand through 2030
  • Retail and online pharmacies, will collectively capture nearly 60% revenue share
  • High-growth markets in APAC to witness heightened activity

“Lack of trust on accuracy and quality and reluctance of individuals to address health issues are key challenges before self-testing market players. Bringing regulations to effect, abidance with prevalent accreditations, and developing transparent solution to fulfil diagnostic requirements of individuals are the order of the day,” says analyst at FMI.

Self-testing Market – Competitive Intelligence
The global self-testing market is highly consolidated with top 5 years accounting for over three-fourths of total market revenue. Leading players are highly focusing on mergers & acquisitions (M&A) to remain competitive in global landscape. Case in point,

  • Procter & Gamble (P&G) has acquired This is L. Inc. – which is among fastest growing feminine care brands in the US – in order to further its commitments to support women and girls as well as its existing feminine care portfolio.
  • Ascensia Diabetes Care Holdings AG has teamed up with POCtech Co. Ltd.to co-develop and distribute continuous glucose monitoring systems.
  • bioMérieux – global leader in vitro diagnostics – has entered into an agreement with Baxter International Inc. – world leader in acute care - to design future biomarkers with the aim to rapidly recognize and offer treatment for acute kidney injury.
  • Siemens Healthineers has taken -based Fast Track Diagnostics (FTD) (Luxembourg), which is global supplier of molecular diagnostic tests.

Key Companies Profiled:

  • ACON Laboratories Inc.
  • ARKRAY Inc.
  • Assure Tech (Hangzhou) Co. Ltd.
  • Becton, Dickinson & Company
  • Bionime Corporation
  • Roche Holding AG
  • Quidel Corporation
  • True Diagnostics Inc.

Comments

Post a Comment

Popular posts from this blog

Monoclonal Antibodies Market to touch US$ 647.01 Billion by 2032; applications abound in Oncology | FMI Report

Image
  Monoclonal Antibodies Market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%. Human mAbs offer efficient modulation in effector functions and are less immunogenic as compared to chimeric or humanized mAbs. Such antibodies can be produced through the use of phage display and hybridoma technologies in transgenic mice. As a result, with recent technological progress in genetic engineering, the production of fully human mAbs is anticipated to gain traction in the near future.  Get Full Access @ https://www.futuremarketinsights.com/reports/monoclonal-antibodies-market North America recorded the largest market share of 46.2% in 2021 due to the presence of a highly developed healthcare infrastructure, high patient awareness, and growth in cancer research pr
Read more

Companion Diagnostics Market Recent Trends, Dynamic Innovation in Technology & Insights 2032

Image
  The global Companion Diagnostics Market is expected to generate approximately US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022, at a CAGR of 7.1% during the forecast period. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Companion Diagnostics market. To read more about this report, visit @ https://www.futuremarketinsights.com/reports/companion-diagnostics-market FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Companion Diagnostics market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcare sector has been expanding remarkably, followi
Read more

Hospital Consumables Market is expected to reach valuation of US$ 853.2 Billion | FMI

  According to Future Market Insights' newly released Hospital Consumables market analysis report, global Hospital Consumables market sales in 2021 are expected to be US$ 346 billion. The estimated market growth of 12.5% between 2022 and 2032 is expected to be much greater than the previous trend. The consumables market is estimated to have a total revenue opportunity of US$ 853.2 billion. The increase in chronic diseases, medical operations, and the expanding older population are driving market expansion. To learn more about this report @ https://www.futuremarketinsights.com/reports/hospital-consumables-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Hospital Consumables market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Hospita
Read more